$38.34
-0.27-0.7%
Last update: Nov 10, 1:24 PM
Acadia Healthcare Co Inc
ACHCNASDAQ
Acadia Healthcare rose 112.5% from $18.17 to a 1-year high of $38.61, ahead of the S&P 500's +10.5%. Its worst day was Jul 29 (−16.3%), and its low came Jan 16 at $11.68.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Adjusted EBITDA Guidance Reduced by $49M and EPS by $0.41, Driven Entirely by an Increase in Professional and General Liability ExpensesAcadia Healthcare Company, Inc.
−14.6% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Acadia Healthcare closed at its lowest level of the year, 35.7% below where the year started.
−1.9% · S&P 500 −0.1%
Acadia Healthcare shares fell 11.5%, while the S&P 500 rose 0.4%.
−11.5% · S&P 500 +0.4%
Acadia Healthcare shares rose 13.7%, while the S&P 500 fell 0.0%.
+13.7% · S&P 500 0.0%
EPS of $0.07 beat the $0.04 estimate on $821.5M revenue (est. $799.5M); Q1 revenue guidance of $820.0M–$830.0M against the $799.5M consensus.
+21.4% · S&P 500 +0.8%
EPS of $0.37 beat the $0.27 estimate on $828.8M revenue (est. $823.7M); Q2 revenue guidance of $835.0M–$850.0M against the $867.2M consensus.
−8.4% · S&P 500 +1.0%
EPS of $0.38 beat the $0.36 estimate on $865.8M revenue (est. $845.6M); FY revenue guidance of $3.4B–$3.5B against the $3.4B consensus.
−16.3%, the year's worst day · S&P 500 −1.5%
EPS of $0.60 beat the $0.46 estimate on $895.3M revenue (est. $876.1M); FY revenue guidance of $3.4B–$3.5B against the $3.4B consensus.
+7.9% · S&P 500 −4.4%
Where it ended: a 1-year high close of $38.61 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.38, revenue est. $859.2M).
Nothing in the past 12 months.
All ACHC dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ACHC and SPY from Benzinga historical bars. Not investment advice.
